ISIS PHARMACEUTICALS, INC. Chart calendar ISIS Pharmaceuticals, Inc.
02a75457.px4_yyOOG5S4gc52yUpk5eclKVwQARbvGbUOqLR3Sj0.70FN-GDEUP79yPcZ-ywU1LZLZiR1ZlK4fdxpn-IhC3fSdmaPb_5Mx93irQ~fbd4eb8d38d027dae05e65331a374b92
Upcoming events on ISIS Pharmaceuticals, Inc.
Past events on ISIS Pharmaceuticals, Inc.
| 21/06/2024 01:00 am | TD Cowen Genetic Medicines & RNA Summit |
| 12/06/2024 12:50 am | Goldman Sachs Global Healthcare Conference |
| 07/06/2024 03:00 am | Annual General Meeting |
| 31/05/2024 05:30 pm | European Academy of Allergy and Clinical Immunology Meeting |
| 14/05/2024 11:10 pm | BofA Securities Health Care Conference |
| 14/05/2024 08:00 pm | RBC Capital Markets Global Healthcare Conference |
| 07/05/2024 09:00 pm | Q1 2024 Earnings Call |
| 07/05/2024 04:30 pm | Q1 2024 Earnings Release |
| 09/04/2024 12:30 am | Needham Healthcare Conference |
| 08/04/2024 07:30 pm | Olezarsen Balance Phase 3 Study Results Call |
| 07/04/2024 07:38 pm | American College of Cardiology Scientific Meeting |
| 07/04/2024 06:00 pm | American College of Cardiology Scientific Meeting |
| 07/04/2024 | American College of Cardiology Scientific Meeting |
| 20/03/2024 08:00 pm | Stifel CNS Day |
| 05/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 21/02/2024 10:00 pm | Q4 2023 Earnings Call |
| 21/02/2024 05:30 pm | Q4 2023 Earnings Release |
| 11/01/2024 04:30 am | JPMorgan Healthcare Conference |
| 04/12/2023 | BMO Growth & ESG Conference |
| 28/11/2023 08:30 pm | Piper Sandler Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 123 1 029 9.18% | 729 712 2.33% | 810 658 23.08% | 587 585 0.33% | 788 634 24.31% | 598 |
|
EBITDA Million USD | Released Forecast Spread | 378 267 41.94% | -159 -94,0 -68.92% | 130 -194 167.11% | -396 -342 -15.71% | -343 -399 14.09% | -551 |
|
EBIT Million USD | Released Forecast Spread | 366 286 28.03% | -172 -111 -55.2% | -30,0 -202 85.16% | -411 -362 -13.5% | -353 -464 23.98% | -577 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 347 281 23.62% | -170 -107 -59.01% | -30,0 -207 85.53% | -258 -349 26.08% | -334 -455 26.55% | -570 |
|
Net income Million USD | Released Forecast Spread | 294 258 13.81% | -451 -77,1 -484.89% | -29,0 -197 85.26% | -270 -354 23.77% | -366 -473 22.64% | -573 |
|
EPS USD | Released Forecast Spread | 2,08 1,77 17.31% | -3,23 -0,52 -516.11% | -0,20 -1,53 86.92% | -1,90 -2,60 26.96% | -2,56 -3,33 23.13% | -3,79 |
| Announcement Date | 26/02/20 | 24/02/21 | 24/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 142 125 13.43% | 134 143 -6.06% | 160 146 9.84% | 152 160 -5.12% | 131 127 3.24% | 188 142 32.47% | 144 136 5.58% | 325 171 90.17% | 119 136 -12.76% | 146 | 157 | 174 | 139 | 177 |
|
EBITDA Million USD | Released Forecast Spread | -53,8 -93,0 42.15% | -81,7 -94,0 13.05% | -55,3 -77,0 28.13% | -205 -205 0% | -111 -127 12.29% | -141 -86,0 -63.65% | -3,46 -117 97.03% | -147 -156 5.81% | -142 | -128 | -119 | |||
|
EBIT Million USD | Released Forecast Spread | -57,0 -105 45.46% | -86,0 -91,5 6.01% | -59,0 -105 43.61% | -208 -157 -32.33% | -114 -138 17.55% | -91,0 -124 26.34% | -143 -153 6.77% | -6,00 -127 95.27% | -150 -157 4.17% | -149 | -149 | -142 | -186 | -137 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,0 -104 38.71% | -103 -91,6 -12.4% | -47,0 -104 54.97% | -44,0 -131 66.52% | -113 -138 17.82% | -77,0 -123 37.23% | -141 -149 5.28% | -3,00 -123 97.56% | -143 -161 11.32% | -144 | -144 | -142 | -204 | -164 |
|
Net income Million USD | Released Forecast Spread | -65,0 -101 35.75% | -105 -88,3 -18.96% | -47,0 -103 54.25% | -52,0 -130 60.12% | -124 -141 12.29% | -85,0 -123 31.12% | -147 -147 0.12% | -9,00 -117 92.3% | -143 -157 9.19% | -143 | -144 | -141 | -205 | -165 |
|
EPS USD | Released Forecast Spread | -0,46 -0,72 35.92% | -0,74 -0,64 -15.94% | -0,33 -0,75 55.98% | -0,37 -0,92 59.82% | -0,87 -0,91 4.67% | -0,60 -0,88 31.71% | -1,03 -1,03 -0.01% | -0,06 -0,86 93.05% | -0,98 -1,07 8.71% | -0,95 | -0,97 | -0,92 | -1,28 | -1,04 |
| Announcement Date | 04/05/22 | 09/08/22 | 09/11/22 | 22/02/23 | 03/05/23 | 09/08/23 | 02/11/23 | 21/02/24 | 07/05/24 | - | - | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for ISIS Pharmaceuticals, Inc.
| 07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
